https://es.wikipedia.org/wiki/OKT3
Muromonab-CD3 - Wikipedia, la enciclopedia libre
wikipedialaenciclopedialibre
https://adisinsight.springer.com/drugsafety/800215007?error=cookies_not_supported&code=d7c70bac-4f9b-4b2b-9e64-06a370b22c22
Antilymphocyte globulin/muromonab CD3 - AdisInsight
Post-transplant lymphoproliferative disorder (PTLD) was observed in 2.5% of 162 renal transplant recipients and was significantly associated with antilymphocyte
adisinsight